Cardinal Health opened higher at $255.02, compared with its previous close of $251.09. In the last trading session, the stock traded between $252.43 and $259.84. It showed an upward intraday trend.
return calculator
Time Period
An investment of $100 made 5 years ago in Cardinal Health is now worth
$ 531.07
giving a profit of
$ 431.07 (431.07%)
invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 13 Analysts
Buy
84.62%
Hold
15.38%
Sell
0%
Markets Today
Today's Change
+$2.81 (+1.12%)
Day High
$259.84
Day Low
$252.43
Day Open
$255.02
Prev Close
$251.09
Volume
6,87,287
1W Return
-0.72%
1M Return
13.38%
3M Return
10.79%
6M Return
25.19%
1Y Return
54.38%
Fundamentals
Market Cap ($ Mn)
58,794
PE Ratio
32.44
PB Ratio
-
PEG Ratio
1.15
ROE
-
ROCE
20.29%
EPS (TTM)
$1.69
Investment Returns
1 Week
-0.72%
1 Month
13.38%
3 Months
10.79%
6 Months
25.19%
9 Months
20.20%
Financials
Quarterly
All values in $ Mn
54.9K
Mar 25
60.2K
Jun 25
64.0K
Sep 25
65.6K
Dec 25
60.9K
Mar 26
63.7K
Jun 26
Updates
20Oct
Mizuho raises Cardinal Health price target to $280, maintains Outperform
Mizuho raises Cardinal Health price target from $250 to $280. Mizuho maintains Outperform rating on the stock. UBS previously raised its price target to $295 with a Buy rating. Two analysts now hold positive ratings with targets above $280.
10 days ago
1Oct
Cardinal Health, McKesson extend CVS distribution deals through 2032
Cardinal Health and McKesson extended pharmaceutical distribution agreements with CVS Health through June 30, 2032. Cardinal Health reaffirmed FY27 adjusted EPS guidance of $12.40-$12.60, beating the $12.04 consensus. McKesson reiterated FY27 adjusted EPS outlook of $44.20-$45 and long-term growth guidance of 13%-16%. McKesson shares rose 4.28% to $890.35, while Cardinal Health shares gained 2.94% to $229.05.
29 days ago
20Sep
Cardinal Health 414, LLC sued over alleged unpaid employee expenses
Class action filed against Cardinal Health 414, LLC in San Diego County Superior Court. Case No. 26CU041886C alleges violations of multiple California Labor Code sections. Complaint cites failure to reimburse business expenses, including personal cell phone usage. Additional claims include unpaid overtime, minimum wages, and inaccurate wage statements.
1mo ago
19Aug
RBC Capital initiates coverage on Cardinal Health with Outperform rating
RBC Capital analyst Ryan Halsted has initiated coverage on Cardinal Health (NYSE: CAH) with an Outperform rating. The firm announced a price target of $276 for the stock.
2mo ago
12Aug
UBS raises Cardinal Health price target to $280 on Buy rating
UBS maintains a Buy rating on Cardinal Health (NYSE: CAH) while increasing its price target from $274 to $280. Analyst Kevin Caliendo issued the update, reflecting a positive outlook on the stock's valuation.
2mo ago
12Aug
Cardinal Health Q4 Results: EPS beats by 20%, sales miss estimates
Cardinal Health Inc posted Q4 adjusted EPS of $2.91, beating estimates of $2.42, while revenue of $63.67 billion missed expectations of $65.03 billion. The company raised buyback authority by $5 billion and issued FY27 EPS guidance of $12.40-$12.60, above consensus.
